A Medina-Remón1, A Tresserra-Rimbau2, A Pons3, J A Tur3, M Martorell3, E Ros4, P Buil-Cosiales5, E Sacanella1, M I Covas6, D Corella7, J Salas-Salvadó8, E Gómez-Gracia9, V Ruiz-Gutiérrez10, M Ortega-Calvo11, M García-Valdueza12, F Arós13, G T Saez14, L Serra-Majem15, X Pinto16, E Vinyoles17, R Estruch1, R M Lamuela-Raventos18. 1. Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Spain; CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain. 2. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Nutrition and Food Science Department, XaRTA, INSA, Pharmacy School, University of Barcelona, Barcelona, Spain. 3. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Spain. 4. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Lipid Clinic, Endocrinology and Nutrition Service, IDIBAPS, Hospital Clinic, Barcelona, Spain. 5. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, and Servicio Navarro de Salud-Osasunbidea, Pamplona, Spain. 6. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Cardiovascular Risk and Nutrition Research Group, IMIM-Institut de Recerca Hospital del Mar, Barcelona, Spain. 7. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Department of Preventive Medicine and Public Health, Nutrition and Food Sciences, School of Medicine, University of Valencia, Spain. 8. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Human Nutrition Unit, School of Medicine, IISPV, University Rovira i Virgili, Reus, Spain. 9. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Department of Epidemiology, School of Medicine, University of Malaga, Spain. 10. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Nutrition and Lipids Metabolism, Instituto de la Grasa, Consejo Superior de Investigaciones Cientificas, Sevilla, Spain. 11. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Department of Family Medicine, Primary Care Division of Sevilla, Esperanza Macarena Health Center, Sevilla, Spain. 12. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Institut Universitari d'Investigació en Ciències de la Salut(IUNICS), Palma de Mallorca, Spain. 13. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Clinical Trials Unit, Hospital Universitario de Araba(HUA), Vitoria, Spain. 14. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Department of Biochemistry and Molecular Biology Service of Clinical Analysis, Hospital General Universitario, Universitat de Valencia, Spain. 15. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Research Institute of Biomedical and Health Sciences of Las Palmas, IUIBS, University of Las Palmas de Gran Canaria, Spain. 16. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Lipid and Vascular Risk Unit, Department of Internal Medicine, Hospital Universitari de Bellvitge, University of Barcelona, Spain. 17. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Mina Primary Care Center, University of Barcelona, Spain. 18. CIBER: CB06/03, CB12/03 Fisiopatología de la Obesidad y la Nutrición(CIBERobn), Instituto de Salud Carlos III(ISCIII), Spain; Nutrition and Food Science Department, XaRTA, INSA, Pharmacy School, University of Barcelona, Barcelona, Spain. Electronic address: lamuela@ub.edu.
Abstract
BACKGROUND AND AIM: Hypertension is one of the main cardiovascular risk factors in the elderly. The aims of this work were to evaluate if a one-year intervention with two Mediterranean diets (Med-diet) could decrease blood pressure (BP) due to a high polyphenol consumption, and if the decrease in BP was mediated by plasma nitric oxide (NO) production. METHODS AND RESULTS: An intervention substudy of 200 participants at high cardiovascular risk was carried out within the PREDIMED trial. They were randomly assigned to a low-fat control diet or to two Med-diets, one supplemented with extra virgin olive oil (Med-EVOO) and the other with nuts (Med-nuts). Anthropometrics and clinical parameters were measured at baseline and after one year of intervention, as well as BP, plasma NO and total polyphenol excretion (TPE) in urine samples. Systolic and diastolic BP decreased significantly after a one-year dietary intervention with Med-EVOO and Med-nuts. These changes were associated with a significant increase in TPE and plasma NO. Additionally, a significant positive correlation was observed between changes in urinary TPE, a biomarker of TP intake, and in plasma NO (Beta = 4.84; 95% CI: 0.57-9.10). CONCLUSIONS:TPE in spot urine sample was positively correlated with plasma NO in Med-diets supplemented with either EVOO or nuts. The statistically significant increases in plasma NO were associated with a reduction in systolic and diastolic BP levels, adding to the growing evidence that polyphenols might protect the cardiovascular system by improving the endothelial function and enhancing endothelial synthesis of NO.
RCT Entities:
BACKGROUND AND AIM: Hypertension is one of the main cardiovascular risk factors in the elderly. The aims of this work were to evaluate if a one-year intervention with two Mediterranean diets (Med-diet) could decrease blood pressure (BP) due to a high polyphenol consumption, and if the decrease in BP was mediated by plasma nitric oxide (NO) production. METHODS AND RESULTS: An intervention substudy of 200 participants at high cardiovascular risk was carried out within the PREDIMED trial. They were randomly assigned to a low-fat control diet or to two Med-diets, one supplemented with extra virgin olive oil (Med-EVOO) and the other with nuts (Med-nuts). Anthropometrics and clinical parameters were measured at baseline and after one year of intervention, as well as BP, plasma NO and total polyphenol excretion (TPE) in urine samples. Systolic and diastolic BP decreased significantly after a one-year dietary intervention with Med-EVOO and Med-nuts. These changes were associated with a significant increase in TPE and plasma NO. Additionally, a significant positive correlation was observed between changes in urinary TPE, a biomarker of TP intake, and in plasma NO (Beta = 4.84; 95% CI: 0.57-9.10). CONCLUSIONS: TPE in spot urine sample was positively correlated with plasma NO in Med-diets supplemented with either EVOO or nuts. The statistically significant increases in plasma NO were associated with a reduction in systolic and diastolic BP levels, adding to the growing evidence that polyphenols might protect the cardiovascular system by improving the endothelial function and enhancing endothelial synthesis of NO.
Authors: J Saban-Ruiz; M Fabregate-Fuente; R Fabregate-Fuente; A Andres-Castillo; A Palomino-Antolin; D Barrio-Carreras; L Martin-Fernandez; F Altamirano; C Fernandez-Fernandez; C Andres-Lacueva Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Miguel Á Martínez-González; Miguel Ruiz-Canela; Adela Hruby; Liming Liang; Antonia Trichopoulou; Frank B Hu Journal: J Nutr Date: 2015-04-01 Impact factor: 4.798
Authors: Mary Anne Nascimento-Souza; Pedro Gontijo de Paiva; Jara Pérez-Jiménez; Sylvia do Carmo Castro Franceschini; Andréia Queiroz Ribeiro Journal: Eur J Nutr Date: 2016-11-21 Impact factor: 5.614
Authors: Estefanía Toledo; Dong D Wang; Miguel Ruiz-Canela; Clary B Clish; Cristina Razquin; Yan Zheng; Marta Guasch-Ferré; Adela Hruby; Dolores Corella; Enrique Gómez-Gracia; Miquel Fiol; Ramón Estruch; Emilio Ros; José Lapetra; Montserrat Fito; Fernando Aros; Luis Serra-Majem; Liming Liang; Jordi Salas-Salvadó; Frank B Hu; Miguel A Martínez-González Journal: Am J Clin Nutr Date: 2017-08-16 Impact factor: 7.045
Authors: Ismael Alvarez-Alvarez; Estefanía Toledo; Oscar Lecea; Jordi Salas-Salvadó; Dolores Corella; Pilar Buil-Cosiales; María Dolores Zomeño; Jesús Vioque; J Alfredo Martinez; Jadwiga Konieczna; Francisco J Barón-López; José López-Miranda; Ramon Estruch; Aurora Bueno-Cavanillas; Ángel M Alonso-Gómez; Josep A Tur; Francisco J Tinahones; Lluís Serra-Majem; Vicente Martín; Manuel Ortega-Calvo; Clotilde Vázquez; Xavier Pintó; Josep Vidal; Lidia Daimiel; Miguel Delgado-Rodríguez; Pilar Matía; José I González; Andrés Díaz-López; Indira Paz-Graniel; Miguel A Muñoz; Montse Fito; Salvador Pertusa-Martinez; Itziar Abete; Antonio García-Ríos; Emilio Ros; Miguel Ruiz-Canela; Miguel Á Martínez-González Journal: Eur J Nutr Date: 2019-05-09 Impact factor: 5.614
Authors: C E Storniolo; R Casillas; M Bulló; O Castañer; E Ros; G T Sáez; E Toledo; R Estruch; V Ruiz-Gutiérrez; M Fitó; M A Martínez-González; J Salas-Salvadó; M T Mitjavila; J J Moreno Journal: Eur J Nutr Date: 2015-10-08 Impact factor: 5.614